| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |